Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Licensing revenue
Expenses:
General and administrative	3,532,302	4,545,884
Research and development	279,489
Depreciation and amortization	11,835	15,004
Total operating expenses	3,823,626	4,560,888
Loss from operations	(3,823,626)	(4,560,888)
Other income (expense):
Forgiveness of accounts payable		351,241
Interest income	55,434	11,689
Sale of royalty and milestone rights, net of transaction costs	4,167,219
Other income (expense), net	1,416	(2,615)
Net Income (Loss)	400,443	(4,200,573)
Dividends paid on preferred shares	(68,809)	(561,381)
Net income (loss) attributable to common stockholders	$ 331,634	$ (4,761,954)
Basic income (loss) per share	$ 0.68	$ (0.11)
Diluted income (loss) per share	$ 0.68	$ (0.11)
Basic weighted average shares outstanding	488,392	450,374
Diluted weighted average shares outstanding	488,392	450,374